About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, March 23rd, 2018

The QualityStocks
Daily Stock List


Boston Therapeutics, Inc. (BTHE)

MissionIR, Tiny Gems, SmallCapVoice, PennyStocks24, FeedBlitz, Wall Street Mover, RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, and Information Solutions Group reported earlier on Boston Therapeutics, Inc. (BTHE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline centers on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. OTCQB-listed, Boston Therapeutics is based in Lawrence, Massachusetts.

The Company’s product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to lessen post-meal glucose elevation. BTI-320 is a proprietary polysaccharide.

BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, reducing the availability of glucose for absorption into the bloodstream.

Boston Therapeutics entered a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. In addition, the Company’s product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it at first is to treat lower limb ischemia associated with diabetes.

Boston Therapeutics’ product pipeline also includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is the Company’s veterinary facsimile to IPOXYN™.

Furthermore, Boston Therapeutics developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose.

SUGARDOWN®, in its present formulation, is a natural sugar blocker dietary supplement product made completely from a non-digestible sugar molecule, which can help people maintain healthier weight levels. It is the first chewable tablet of its kind.

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical Company Limited (APC), began the SUGARDOWN® clinical trial in Hong Kong. Advance is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.

In April 2017, Boston Therapeutics and Advance Pharmaceutical announced the fully funded new trial plans to support the safety and efficacy of BTI-320, starting with a randomized, placebo-controlled, double-blinded, multi-center, global study on type 2 diabetic (T2D) patients.

Last month, Boston Therapeutics announced that effective sugar reduction with the investigative BTI-320 formulation necessitates only one tablet. Findings were confirmed by the most recent proof-of-concept study conducted in high-risk Chinese subjects with pre-diabetes. A formulation, in the form of a dietary supplement, is currently available as SUGARDOWN®, SUGARBLOCK and SUGARBALANCE in the Unites States and Asia.

Moreover, in December, Boston Therapeutics announced that it expanded its partnership with Advance Pharmaceutical Company Limited (APC) to distribute in Korea. Following the extension of the licensing and distribution agreement with APC, a registered formulation, marketed as a food supplement under the name SUGARBALANCE is now available in Korea. This significant shipment marks a start to the sales of SUGARBALANCE in the territory.

Boston Therapeutics, Inc. (BTHE), closed Friday's trading session at $0.08, up 8.11%, on 18,948 volume with 6 trades. The average volume for the last 60 days is 52,702 and the stock's 52-week low/high is $0.025/$0.1164.

Esports Entertainment Group, Inc. (GMBL)

Real Pennies reported earlier on Esports Entertainment Group, Inc. (GMBL), and today we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Esports Entertainment Group, Inc. is a next generation, licensed, online gambling business specifically centered on eSports wagering. Its intention is to offer wagering on eSports events in a fully licensed, regulated, and secured platform to the global eSports audience, excluding the United States. Esports Entertainment Group has offices in St. Mary's, Antigua and Barbuda.

In essence, Esports Entertainment Group is a licensed online gambling company with a particular focus on eSports wagering and 18+ gaming. A team of industry and technical experts from the online gambling and video game industries, and e-Sports, marketing, legal, and financial professionals lead Esports Entertainment Group.

Esports is focusing on launching its online Esports gambling platform. This platform will be completely licensed and the highest regulated esports gambling site internationally.

Additionally, Esports intention is to offer users around the world the ability to participate in multi-player video games tournaments online for cash prizes. At present, the Company is developing several play money websites and its real money wagering website.

Esports Entertainment Group has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. Esports has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on an international basis from centers in Canada and Antigua.

Moreover, Esports has an agreement with CAMS, LLC to provide worldwide electronic payment and risk management solutions. Esports has a peer-to-peer wagering system. It will provide real money betting exchange style wagering on all professional eSports events.

Esports Entertainment Group announced in October of 2017 the execution of a Letter of Intent (LOI) to acquire all of the issued and outstanding securities of Ardmore Investments SP. Z O.O. Ardmore is a subsidiary of Switzerland based gambling software developer Swiss Interactive Software GmbH. Also, Esports has received its Curacao eGaming License.

This week, Esports Entertainment Group announced the launch of VIE (https://vie.gg). The Company states that this is the world’s safest, most secure and transparent esports wagering platform.

VIE offers bet exchange style wagering on esports events in a licensed, regulated and secured platform to the worldwide esports audience. This excludes jurisdictions such as the United States, which prohibit online gambling.

The bet exchange model provides for player versus player betting (PVP). The house takes a small percentage of each wager. This is versus a sports book model that pits the player versus the house.

Esports Entertainment Group, Inc. (GMBL), closed Friday's trading session at $0.94, up 0.32%, on 4,650 volume with 6 trades. The average volume for the last 60 days is 3,302 and the stock's 52-week low/high is $0.249/$3.14.

Protalex, Inc. (PRTX)

StreetInsider, Zacks, TopStockAnalysts, and OTCPicks reported on Protalex, Inc. (PRTX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Protalex, Inc. is a clinical-stage Biopharmaceutical Company based in Florham Park, New Jersey. Its emphasis is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA (Rheumatoid Arthritis) and ITP (Immune Thrombocytopenia). The Company’s lead product is PRTX-100. This is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. Protalex’s shares trade on the OTC Markets Group’s OTCQB.

Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising because of the body’s inability to form blood clots.

Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through reducing the immune-mediated destruction of the platelets. Protalex has open IND’s for the treatment of RA and ITP in the United States, and in Europe, an open IMPD for ITP.

Protalex’s PRTX-100 can (at very low concentrations) bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the United States and in Europe for the treatment of ITP. This status provides commercial exclusivity benefits, tax credits for certain research, potential research grants and a waiver of the New Drug Application user fee in the United States. Currently, it is the subject of clinical studies in the U.S. and Europe.

PRTX-100 is administered as a short intravenous infusion. The following patents have been granted for PRTX-100: U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.

European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to numerous autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion.

Canadian patents No. 2,894,098 and No. 2,481,282 comprise method of treatment claims relating to RA and SLE.

Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris.

Recently, Protalex announced that following a planned interim analysis of data from the fourth dose cohort of its European Phase 1b study of PRTX-100 (PRTX-100-203 Study) in adults with persistent/chronic Immune Thrombocytopenia (ITP), it initiated enrollment in the fifth and highest dose cohort of this dose-escalating study.

The first patient in the final cohort was recently dosed in the United Kingdom at 24 micrograms/kg. This the highest dose of PRTX-100 used in any clinical trial to date. One of the three patients treated in the fourth dose cohort (18 micrograms/kg) attained a protocol defined platelet response.

Protalex, Inc. (PRTX), closed Friday's trading session at $0.44, even for the day. The average volume for the last 60 days is 1,750 and the stock's 52-week low/high is $0.312/$3.00.

Advanced BioMedical Technologies, Inc. (ABMT)

Zacks, Stockrow, and 4-Traders reported on Advanced BioMedical Technologies, Inc. (ABMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments. The Company has treated more than 15,000 patients during the past 28 years. It is a leader in education, research, training, and instrument sales and works with doctors and clinicians throughout the U.S. This includes those in Minnesota, the majority of which have an affiliation with the University of Minnesota. Advanced BioMedical Technologies is based in Eagan, Minnesota.

The Company is the oldest distributor of the Electro-Acuscope and Electro-Myopulse. Advanced BioMedical has a 6,000-square foot office complex, with 3,000 square feet dedicated as a patient care treatment center.

The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).

The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Similarly, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.

The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.

The Neuroscope 230B (Home Care Unit) is for the personal treatment of sleep, anxiety, and pain issues. The product is a personal treatment device for the person on the go. Moreover, it is as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy require more treatments at home.

The design of the Electro-Acuscope 85P (Portable) instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.

Furthermore, Advanced BioMedical Technologies has its La Fleur products. These include the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics), which was developed exclusively by the Company. In addition, the Company carries a line of Accessories.

Recently, Advanced Biomedical Technologies announced that the State Intellectual Property Office of The People’s Republic of China (SIPO) issued the Company a new patent titled “Bone Fracture Plate Made of High Polymer Materials”.

Its subsidiary Shenzhen Changhua Biomedical Engineering Company Limited is entitled for the new patent (ZL 2014 1 0647464.1), which strengthens the Company's position in manufacturing process and related controls using its innovative polyamide materials (PA).

Advanced BioMedical Technologies, Inc. (ABMT), closed Friday's trading session at $0.18, up 13.92%, on 3,500 volume with 2 trades. The average volume for the last 60 days is 771 and the stock's 52-week low/high is $0.10/$0.21.

GripeVine, Inc. (GRPV)

MarketWatch, InvestorsHangout, InvestorsHub, Morningstar, and Stockhouse reported on GripeVine, Inc. (GRPV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

GripeVine, Inc. is a company focusing on leading the revolution of social customer service. The Company is a proprietary complaint-resolution platform for the facilitation and management of social customer service through centralized communication, rating, and review tools. It has a highly scalable and sustainable growth model. GripeVine is based in Oakville, Ontario.

The Company’s mission is to establish itself as a worldwide leader in social consumer resolution and relationship management. It works to accomplish this through providing businesses strong tools to manage their social presence while providing consumers with tangible resolution results and a social engine.

GripeVine has a platform where, as the Company states, all sides can be heard. It has a user-friendly social CRM (Customer Relationship Management) platform for users to engage on.

The emphasis is on turning negative experiences into positive outcomes. Consumers with legitimate customer service complaints can post it (plant a gripe) and connect with companies who subsequently can interact with their customers on a level playing field to find a harmonious resolution.

GripeVine provides a thriving social engine for consumers and premier back end tools for businesses. GripeVine develops, owns, and operates social customer relations applications on desktop and mobile computing platforms.

The Company has unique patents. These patents drive a flourishing community and provide businesses first-rate control over their social public image.

The GripeVine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. The Company’s platform includes the handling of ratings, reviews, and complaint resolution statuses. This is while offering data collection features including scoring, polling, comments, voting, and credibility points – all with the goal of creating a home for connections, resolution, business improvement, and loyalty enhancement.

High profiles companies and localized SME’s (small and medium-sized enterprises) use GripeVine. The Company expedites the resolution process between consumers and businesses. In essence, GripeVine creates a fair space for business and consumers to interact.

GripeVine, Inc. (GRPV), closed Friday's trading session at $0.20, up 5.32%, on 66,200 volume with 10 trades. The average volume for the last 60 days is 8,655 and the stock's 52-week low/high is $0.065/$1.00.

Namaste Technologies, Inc. (NXTTF)

OTC Markets, MarketWatch, InvestorsHub, Stockhouse, InvestorsHangout, TradingView, and Daily Marijuana Observer reported on Namaste Technologies, Inc. (NXTTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Namaste Technologies, Inc. is the largest online retailer for medical cannabis delivery systems globally. The Company distributes vaporizers and smoking accessories by way of e-commerce sites in 26 countries and with 5 distribution hubs located worldwide. Namaste’s long term strategy is to become a top supplier of legal cannabis products as the cannabis market is legalized in each nation. Namaste Technologies is headquartered in Toronto, Ontario. The Company’s U.S. office is in Jupiter, Florida and its Bahamas office is in Lyford Cay.

Namaste Technologies owns and operates online retail sites with a presence in many nations. The Company is an international leader in delivery systems for dry herbs, which can include medicinal cannabis where legally available. Through vaporizer sales and the selling of glass and pipes and other dry herb related paraphilia, Namaste has a very strong channel to sell to end consumers once it is legalized globally.

Namaste has acquired Cannmart, Inc. This is a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program). Through Cannmart, Namaste Technologies is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market.

Namaste is in the final stages of its Cannmart license to gain approval to distribute cannabis in Canada. Legalization is in the final stages in Canada. It received approval in the Canadian Senate yesterday.

Namaste Technologies is also active in product development and manufacturing. It will launch the Grizzly Eclipse Vaporizer soon.

Namaste has majority market share in Europe and Australia. The Company has operations in the United Kingdom, the United States, Canada and Germany. Additionally, it has opened new supply channels into developing markets. This includes Brazil, Mexico, and Chile.

This week, Namaste Technologies announced that its wholly-owned subsidiary, Cannmart received its Access to Cannabis for Medical Purposes Regulations (ACMPR) Production License. Under the guidelines from Health Canada, Cannmart may now place initial orders with ACMPR licensed producers.

Sean Dollinger, Namaste Technologies’ President and Chief Executive Officer, said, “This important milestone represents an incredible achievement for Namaste and its shareholders. Receipt of the ACMPR Production License not only validates Namaste’s strategy but it serves as a critical component of the Company’s anticipated growth moving forward. We are very proud to have met our goal of receiving our ACMPR medical cannabis Production License from Health Canada as we look to explore the tremendous opportunities that exist in the Canadian cannabis market.”

Yesterday, Namaste Technologies announced that it signed a non-binding Terms Sheet with PharmaCann Pty Ltd. Namaste will participate in an investment to purchase a 10 percent equity position in PharmaCann.

At present, PharmaCann operates with existing licenses to import, export, and also wholesale medical cannabis issued by the Australian Government Department of Health. Namaste Technologies’ investment in PharmaCann will be used by PharmaCann to proceed with its application to further secure a cultivation license.

Namaste Technologies, Inc. (NXTTF), closed Friday's trading session at $1.55, up 4.73%, on 354,611 volume with 294 trades. The average volume for the last 60 days is 796,022 and the stock's 52-week low/high is $0.1319/$3.4715.

Uniroyal Global Engineered Products, Inc. (UNIR)

MarketWatch, Zacks, and Marketbeat reported on Uniroyal Global Engineered Products, Inc. (UNIR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., via its subsidiaries, is a top manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, as well as other synthetic fabric coverings. Established in 1992; Uniroyal Global Engineered Products (UNIR) has its corporate office Sarasota, Florida. The Company’s shares trade on the OTC Markets’ OTCQB.

UNIR’s main brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. Additionally, its brand names include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.

UNIR is a foremost supplier of vinyl coated fabric materials for the automotive and commercial industries. Its products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and trim components.

The Company’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.

In 2016, UNIR’s Naugahyde brand introduced Casablanca. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.

All of Casablanca’s patterns are flame retardant, stain resistant, and anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish. This collection was developed with hospitality, contract, marine, and healthcare markets in mind.

This week, UNIR reported its financial results for the fiscal year ended December 31, 2017. Net Sales for the fiscal year declined 2.2 percent to $98,138,060 in comparison $100,377,278 in the prior year. Excluding currency translations, organic sales would have declined 1.7 percent from the prior year.

A decline in Operating Income this year in comparison to the prior year, combined with a tax charge of $2.9 million this year in comparison to a tax benefit in the prior year, resulted in a Net Loss of $3,102,130 available to Common Shareholders versus Net Income of $4,499,664 reported the year prior.

The Company’s Revenue in 2017 was derived 67.5 percent from the automotive industry and roughly 32.5 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality and health care markets.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Friday's trading session at $1.40, up 12.00%, on 24,910 volume with 18 trades. The average volume for the last 60 days is 2,780 and the stock's 52-week low/high is $1.00/$3.55.

OrangeHook, Inc. (ORHK)

OTC Markets, Stockopedia, TradingView, Barchart, Simply Wall St, and Stockhouse reported on OrangeHook, Inc. (ORHK), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Established in 2014, OrangeHook, Inc. is an international leader in identity solutions. The Company is working to become the leader in converged credentials, which directly link identity with Big Data sets, accountability, payments and healthcare. Listed on the OTC Markets’ OTCQB, OrangeHook is headquartered in Wayzata, Minnesota.

The Company’s key areas of focus are Identification, Patient Validation, and Secure Payment Authentication. OrangeHook has more than 20 active patents that support its corporate strategy.

The Company has 19,000 active clients, as well as 5 portfolio companies (Salamander, LifeMed ID, Agilivant, Nuvel, and LifeNexus). OrangeHook’s solutions can be implemented fast, and in a technologically agnostic way.

Regarding Identification, OrangeHook can deliver identity provisioning to healthcare providers, military, police, fire, airport workers and emergency responders globally.

Concerning Patient Validation, the Company’s patented patient validation solution ensures that patients are who they say they are. Pertaining to Secure Payment Authentication, OrangeHook built out its financial platform to issue EMV bank sponsored cards with the ability to link by way of identity to portable healthcare data.

In October 2017, InXite Health Systems (IHS) and OrangeHook announced that they reached an agreement creating a major strategic relationship for delivery of healthcare infrastructure solutions to the worldwide healthcare market. IHS is a Columbus, Ohio healthcare Information Technology (IT) company.

The strategic product offerings will be based on each of the parties' proprietary technologies. They will include a virtually integrated continuum of care platform powered by IHS’s advanced value-based care platform and OrangeHook's patient identification and payments technologies.

Last week, Bravatek Solutions, Inc. (BVTK) announced that it entered into a Strategic Alliance Agreement with OrangeHook. Bravatek Solutions will act as a project-based business partner for prospective clients in the private and public sectors. The parties intend to concentrate on assisting those that assist people during emergencies—namely, First Responders.

Mr. Jim Mandel, Chairman and Chief Executive Officer of OrangeHook, said: “While we are confident that our respective teams have the capabilities, as well as professional contacts, to assist the many potential markets we serve, we are pleased to be partnering with a firm whose Chairman and CEO has not only written several books to assist our First Responders—but has been an active responder himself for over 36 years. Our teams are excited by this new relationship.”

OrangeHook, Inc. (ORHK), closed Friday's trading session at $2.01, up 0.50%, on 11,110 volume with 10 trades. The average volume for the last 60 days is 246 and the stock's 52-week low/high is $1.5001/$11.20.

Nemus Bioscience, Inc. (NMUS)

MarketWatch, InvestorsHub, OTC Markets, and Zacks reported on Nemus Bioscience, Inc. (NMUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical company, Nemus Bioscience, Inc. centers on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in worldwide markets. The Company’s strategy will explore the use of natural and synthetic compounds, alone or in combination. A highly qualified team of executives with decades of biopharmaceutical experience and significant background in early-stage drug development leads Nemus Bioscience. OTCQB-listed, the Company has its head office in Costa Mesa, California.

Using certain proprietary technology licensed from the University of Mississippi, Nemus Bioscience is working to develop novel ways to deliver cannabinoid-based drugs for specific indications. Its goal is optimizing the clinical effects of such drugs, while limiting the potential adverse events.

Cannabinoids are a class of chemically diverse compounds, which undergo extraction from the cannabis plant. These compounds express their physiological response through binding to specific cannabinoid receptors (CB1 and CB2) that are found throughout the body. Cannabinoids can specifically have impacts on the immune system, nervous system, as well as the body’s organs.

Nemus develops novel and proprietary classes of product candidates. The design of these are to improve therapeutic options by way of enhanced chemical engineering, which allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

Nemus Bioscience brings proprietary bioengineering to cannabinoid-based therapeutics to optimize therapeutic targeting. At present, the Company is the only partner of the University of Mississippi for the development and commercialization of these bioengineered cannabinoid-based drug candidates.

Nemus Bioscience is presently the only cannabinoid drug developer advancing a bioengineered multi-cannabinoid drug platform for the treatment of ocular diseases such as glaucoma. The Company is currently the only cannabinoid drug developer advancing a bioengineered multi-cannabinoid drug platform for the treatment and management of infectious diseases.

Additionally, Nemus is currently the only cannabinoid drug developer employing biosynthetic approaches for the manufacturing of Nemus Bioscience drug products.

Recently, Nemus Bioscience announced that it entered into agreements with Emerald Health Sciences, Inc., including a binding term sheet, Secured Promissory Note for a convertible loan and a Security Agreement. The Bridge Loan provides for aggregate gross proceeds to Nemus Bioscience of up to $900,000. It is secured by all of Nemus’ assets. Nemus received proceeds of $500,000 on December 28, 2017. The agreements provide for the funding of the remaining $400,000 on January 16, 2018.

Nemus Bioscience, Inc. (NMUS), closed Friday's trading session at $0.25, up 4.08%, on 65,596 volume with 37 trades. The average volume for the last 60 days is 484,622 and the stock's 52-week low/high is $0.10/$0.48.

Cannabis Wheaton Income Corp. (CBWTF)

Epic Stock Picks, Investors Hangout, Investopedia, Street Insider, Insider Financial, Investopedia, Wealth Daily, Marketwired, OTC Markets, MarketWatch, Barchart, 4-Traders, and Stock of the Week reported on Cannabis Wheaton Income Corp. (CBWTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cannabis Wheaton Income Corp. operates as a cannabis streaming company. Its mandate is to facilitate growth for its partners through providing them with financial support and sharing the Company’s collective industry experience. Cannabis Wheaton invests and supports a wide spectrum of cannabis cultivation companies. Incorporated in 1987, the Company previously went by the name Knightswood Financial Corp. It changed its name to Cannabis Wheaton Income Corp. in May of 2017.

Cannabis Wheaton’s team has a depth of knowledge from cultivation, regulatory, construction, retail, branding, finance and technology. The Company is using the stream, or streaming model, to finance cannabis companies. It has agreements with greater than a dozen partners.

The Company provides financial support for cannabis facility expansions, operations, and also initial construction. It does so in exchange for minority equity interests and a portion of the cultivation production. Cannabis Wheaton’s partners maintain their brand autonomy. Moreover, they gain access to better scaling flexibility.

In 2017, Cannabis Wheaton and Beleave, Inc. announced that they, along with Beleave's wholly-owned operating subsidiary, Beleave Kannabis Corp., entered a definitive agreement where Cannabis Wheaton will provide Beleave with up to $10,000,000 in non-dilutive debt financing through an instrument evidencing a debt obligation repayable in product equivalents (the D.O.P.E. Note). The proceeds of the D.O.P.E. Note will be used by Beleave to finance the construction of an expansion facility that will be situated next to Beleave's facility outside of Hamilton, Ontario.

Cannabis Wheaton announced in November of 2017 the closing of the acquisition of all of the issued and outstanding shares of RockGarden Medicinals (2014), Inc. pursuant to the terms of a definitive share purchase agreement dated October 31, 2017. RockGarden was granted a cultivation license on August 25, 2017.

The acquisition furthers Cannabis Wheaton’s streaming platform strategy through providing it more resources and regulatory tools to help expedite Wheaton Licensing Program participants' pathway to licensing under the Access to Cannabis for Medical Purposes Regulations (ACMPR). RockGarden is a privately owned licensed producer of cannabis pursuant to the ACMPR.

Fundamentally, Cannabis Wheaton is envisaging a coast-to-coast network. The Company is laying the foundation and facilitating the connections between licensed producers and consumers.

Last month, Cannabis Wheaton Income announced that it entered into a joint venture (JV) with Mr. Peter Quiring, one of Canada’s largest greenhouse builders and operators, through a newly formed subsidiary (GreenhouseCo), to develop, construct and operate a state-of-the-art purpose-built greenhouse for cannabis cultivation (in Leamington, Ontario). Mr. Quiring will act as Chief Executive Officer of GreenhouseCo.

Cannabis Wheaton Income Corp. (CBWTF), closed Friday's trading session at $1.31, up 2.34%, on 997,778 volume with 869 trades. The average volume for the last 60 days is 2,186,283 and the stock's 52-week low/high is $0.5213/$2.70.


The QualityStocks
Company Corner


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF). Today, Choom Holdings Inc. closed trading at $0.7727, up 14.14%, on 349,370 volume with 190 trades. The stock’s average daily volume over the past 60 days is 89,793, and its 52-week low/high is $0.125/$0.8612.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Big and Small Companies Partner Up to Provide Canada's Cannabis," featuring Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF). To hear the NetworkNewsAudio version, visit http://nnw.fm/05zWd. To read the original editorial, visit http://nnw.fm/hhL5e.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™. Disclaimer

Choom Holdings Inc. Company Blog

Choom Holdings Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Choom Holdings Inc. Pairing for Opportunity in Canada's Cannabis Market

NetworkNewsWire Announces Publication on Savvy Partnerships and Investment Ahead of Canada’s Cannabis Boom

NetworkNewsWire Announces Publication on Innovators Aiming High in Canadian Cannabis Industry

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.13 up 13.25%, on 19,958 volume with 14 trades. The stock’s average daily volume over the past 60 days is 58,180, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp. (RGNP) featured on “NEW TO THE STREET,” which brings to the viewing audience a spectrum of companies, each on the threshold of breakthrough in their respective markets.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

NEW TO THE STREET TV Features Advancements in Leading Technologies on the Fox Business Network - Reign Sapphire Corp. (RGNP)

Reign Sapphire Corp. (RGNP) Looks to Release Reign Coin White Paper in Coming Weeks

Reign Sapphire Corp Issues Update on Reign Coin White Paper in Preparation for Launch

AnalytixInsight Inc. (TSX.V:ALY) (OTCQB:ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF). Today, AnalytixInsight Inc. closed trading at $0.3638, up 3.94%, on 17,778 volume with 11 trades. The stock’s average daily volume over the past 60 days is 19,816 and its 52-week low/high is $0.15/$0.6898.

“50 years ago, some 90 per cent of stocks on the New York Stock Exchange were held by individuals trading on their own account,” according to the Financial Times. If this trend continues, the demise of the small investor is imminent. However, reports of that death may be greatly exaggerated, since tech company AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is providing the small guy with the same arsenal of tools wielded by large individual funds.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company's flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube's online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube's freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy's largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo's 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo's established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners. Disclaimer

AnalytixInsight Inc. Blog

AnalytixInsight Inc. News:

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Portal Makes Quant Research Tools Available to Individual Investors

NetworkNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Set to Gain from Wide-ranging Applications for AI

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Develops Proprietary AI Platform as Data-Driven Markets Mature

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.16, up 2.65%, on 195,432 volume with 282 trades. The stock’s average daily volume over the past 60 days is 337,560 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is helping smokers light up less. Using LXRP’s revolutionary technology, smokers could be able to give up smoking without giving up nicotine. With one billion smokers worldwide, companies are seeking safer delivery technologies to help wean smokers from this deadly habit. Through third-party partnerships with major tobacco industry players, LXRP is poised to revolutionize smokeless tobacco (http://cnw.fm/YP8jF).

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Helping Smokers Light Up Less

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for "Composition of Matter" Cannabinoid Delivery

Lexaria Files New Patent Application for Enhanced Transdermal Delivery System

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.22, up 3.39%, on 116,226 volume with 151 trades. The stock’s average daily volume over the past 60 days is 129,955, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF), a company focused on the development and implementation of proprietary technologies for the energy industry, is engaged in developing an environmentally-friendly solution for extracting shale oil as demand for the natural resource rises. To view the full article, visit: http://nnw.fm/T6U2c.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

NetworkNewsBreaks – Petroteq Energy Inc.’s (TSX.V: PQE) (OTCQX: PQEFF) Patented Technology Delivers Environmentally Safe, Profitable Product

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Uses Oil Sands Technology to Get the Dilbit Flowing in Utah

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Creating Value with Disruptive Blockchain Initiative

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.0274, up 0.37%, on 2,241,775 volume with 202 trades. The stock’s average daily volume over the past 60 days is 11,459,927 and its 52-week low/high is $0.0181/$0.0728.

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) recently launched its new CBD-based natural pet product, hempSMART™ Full Spectrum Pet Drops. To view the full article, visit: http://cnw.fm/YF2Zh.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers a Natural Option for Pet Owners with hempSMART Full Spectrum Pet Drops

Marijuana Company of America, Inc. (MCOA) Creating a Diversified Range of Synergistic Opportunities in Hemp Sector

Marijuana Company of America Announces the Offical Launch of Benihemp at the ASD Trade Show


The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF). Today, FANDOM SPORTS Media Corp. closed trading at $0.1193, even for the day. The stock’s average daily volume over the past 60 days is 24,440, and its 52-week low/high is $0.025/$0.3911.

FanDom Sports Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42), an aggregator, curator and producer of unique fan-focused content delivered through its mobile app, recently announced that it has retained the services of corporate communications firm NetworkNewsWire (“NNW”). Also today, NNW released a report on why FDMSF is “One to Watch.” To view the full article, visit: http://nnw.fm/Wtpf8.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric "argument engine" measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company's tag line – "Pick a Fight" – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren't afraid of stepping up to the plate to engage other users by unleashing their opinions within the app's structured debate resolution tool coined "FanFights." Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company's self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying "interactive sports entertainment" to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app's fan base through a Blockchain supported "PlayerCard" in tandem with the "Engagement Score", which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users' very dynamic behavior and sports passion.

FANDOM SPORTS' Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo's service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

"Pick A Fight. Talk Trash. Get Rewarded."

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company's core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company's website at www.fandomsportsmedia.com or contact them directly at info@fandomsportsmedia.com.


The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company's control. Some of these risks and uncertainties may be described in the Company's corporate filings (posted at www.sedar.com).

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events. Disclaimer

FANDOM SPORTS Media Corp. Company Blog

FANDOM SPORTS Media Corp. News:

FanDom Sports Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Retains the Services of NetworkNewsWire

NetworkNewsBreaks – Why FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) is “One to Watch”

FANDOM SPORTS Secures US Government Service Provider as Back-end Technology Partner

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.11, up 0.27%, on 151,593 volume with 39 trades. The stock’s average daily volume over the past 60 days is 354,395, and its 52-week low/high is $0.0045/$0.52.

Epazz, Inc. (EPAZ) was featured this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz, Inc. (OTC PINK: EPAZ) Featured on MoneyTV with Donald Baillargeon, 3/23

Epazz’s Patent Pending Blockchain Smart Legal Contracts (Cordtell) will Generate New Sources of Revenue with Dispute Resolution

NetworkNewsBreaks – Epazz, Inc. (EPAZ) Advances Toward Million User Goal for ZenaPay Cryptocurrency Wallet

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF). Today, Global Hemp Group, Inc. closed trading at $0.116, off by 0.85%, on 268,186 volume with 46 trades. The stock’s average daily volume over the past 60 days is 309,025, and its 52-week low/high is $0.0115/$0.316.

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. To view the full article, visit: http://cnw.fm/4yM0f.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Hemp Group, Inc. Company Blog

Global Hemp Group, Inc. News:

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

NetworkNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Plans to Progress in Industrial Hemp Sector through Strategic Partnerships, Acquisitions

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.04594, off by 7.75%, on 4,792,528 volume with 371 trades. The stock’s average daily volume over the past 60 days is 8,121,031, and its 52-week low/high is $0.0132/$0.415.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTC:SING), a client of NNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. To view the full publication, titled “Blockchain Remains a Potential Powerhouse for Various Markets’ Futures,” visit: http://nnw.fm/x13Cg.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication on Innovators Advancing in Various Sectors with Power of Blockchain

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Roth Capital Conference on MoneyTV

SinglePoint Inc.’s (SING) Launch of Cannabis Payment Solution Covered by NetworkNewsAudio


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(NWY) +25.90%


(SSOF) +24.14%


(AVOP) +23.46%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251